Methotrexate in psoriatic arthritis.
Artigo
em Inglês
| IMSEAR
| ID: sea-92787
ABSTRACT
Thirty three patients with psoriatic arthritis were treated with starting dose of 7.5 mg of methotrexate orally, every week for a period of 6 months to 7 years (mean 2.2 years) along with non-steroidal anti-inflammatory agents. The dose of methotrexate during the course of therapy ranged 5 to 15 mg/week (mean 7.8 mg). There was complete to partial remission in arthritis and psoriatic skin lesions in 94% (31) patients. No response was noticed in 2 patients. Regular monitoring of haematological, renal and liver function tests was done. No significant side effects of the drug, requiring discontinuation of the therapy, were seen during the treatment. Methotrexate can be used early in the course of psoriatic arthritis with good results.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Psoríase
/
Células Sanguíneas
/
Indução de Remissão
/
Humanos
/
Artrite Psoriásica
/
Metotrexato
/
Administração Oral
/
Estudos Retrospectivos
/
Adolescente
/
Adulto
Tipo de estudo:
Estudo observacional
Idioma:
Inglês
Ano de publicação:
1994
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS